Source: Health Canada shortage reports · Updated Jul 9, 2026
Some Fingolimod products are in shortage in Canada (3 of 8 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.
A medication used to treat relapsing forms of multiple sclerosis.
Products affected
3 / 8
In shortage since
Mar 4, 2022
Reports on file
15
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
MYLAN-FINGOLIMOD
0.5MG · CAPSULE · MYLAN PHARMACEUTICALS ULC
DIN 02469715 · since Jul 7, 2025, no end estimate · Disruption of the manufacture of the drug.
Active shortage
APO-FINGOLIMOD
0.5MG · CAPSULE · APOTEX INC
DIN 02469936 · since May 7, 2024, no end estimate · Disruption of the manufacture of the drug.
Active shortage
ACH-FINGOLIMOD
0.5MG · CAPSULE · ACCORD HEALTHCARE INC
DIN 02475669 · since Mar 4, 2022, no end estimate · Disruption of the manufacture of the drug.
Discontinued
TEVA-FINGOLIMOD
0.5MG · CAPSULE · TEVA CANADA LIMITED
DIN 02469561
Discontinued
TEVA-FINGOLIMOD
0.5MG · CAPSULE · TEVA CANADA LIMITED
DIN 02469561
Discontinued
TEVA-FINGOLIMOD
0.5MG · CAPSULE · TEVA CANADA LIMITED
DIN 02469561
Resolved
TEVA-FINGOLIMOD
0.5MG · CAPSULE · TEVA CANADA LIMITED
DIN 02469561 · ended Mar 19, 2025 · Disruption of the manufacture of the drug.
Discontinued
TEVA-FINGOLIMOD
0.5MG · CAPSULE · TEVA CANADA LIMITED
DIN 02469561
Resolved
JAMP FINGOLIMOD
0.5MG · CAPSULE · JAMP PHARMA CORPORATION
DIN 02487772 · ended Mar 21, 2024 · Disruption of the manufacture of the drug.
Resolved
MAR-FINGOLIMOD
0.5MG · CAPSULE · MARCAN PHARMACEUTICALS INC
DIN 02474743 · ended Jul 6, 2022 · Business reasons
DIN 02482533 · ended Jun 6, 2023 · Delay in shipping of the drug.
Resolved
MYLAN-FINGOLIMOD
0.5MG · CAPSULE · MYLAN PHARMACEUTICALS ULC
DIN 02469715 · ended May 1, 2023 · Shortage of an active ingredient.
Showing 12 of 15 reports. All reports are on file with Health Canada.
What's happening
Fingolimod is currently affected by 3 active shortage reports filed with Health Canada by MYLAN PHARMACEUTICALS ULC, APOTEX INC, ACCORD HEALTHCARE INC.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Recent changes
No changes recorded yet.
Common questions
What is Fingolimod used for?
A medication used to treat relapsing forms of multiple sclerosis.
When will Fingolimod be back in stock in Canada?
Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.
Why is Fingolimod in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Possible alternatives in the same class
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.